Generate Biomedicines, Inc. (GENB) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Generate Biomedicines, Inc. (GENB) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.80B, listed on NASDAQ, employing roughly 312 people, carrying a beta of -0.50 to the broader market. Generate Biomedicines, Inc. Led by Michael T. Nally, public since 2026-02-27.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for GENB as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →